Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children.

ABSTRACT:

Background

Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children.

Data sources

The evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using

SUBMITTER: Zhang XL 

PROVIDER: S-EPMC10828005 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature